FourThought Financial’s AbbVie ABBV Stock Holding History

FourThought Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$4.14M	Buy	30,828 +1,379	+5%	+$198K	0.61%	43
2022 Q2	$4.51M	Buy	29,449 +1,616	+6%	+$247K	0.66%	39
2022 Q1	$4.53M	Buy	27,833 +6,364	+30%	+$924K	0.57%	44
2021 Q4	$2.91M	Buy	21,469 +9,844	+85%	+$1.16M	0.37%	63
2021 Q3	$1.25M	Sell	11,625 -1,600	-12%	-$183K	0.17%	118
2021 Q2	$1.49M	Buy	13,225 +23	+0.2%	+$2.59K	0.2%	98
2021 Q1	$1.43M	Buy	13,202 +484	+4%	+$51.8K	0.21%	91
2020 Q4	$1.36M	Buy	+12,718	New	+$1.22M	0.22%	87

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FourThought Financial's ABBV Position: Q3 2022 in Review

FourThought Financial increased its AbbVie (ABBV) stake by 4.7% in Q3 2022, buying an estimated $198K and bringing the position to 30,828 shares worth $4.14M. The position accounts for 0.61% of the portfolio, ranked #43.

FourThought Financial first reported a position in ABBV in Q4 2020 and has held it in 8 quarters since. The position peaked at $4.53M in Q1 2022. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

FourThought Financial held 30,828 shares of AbbVie worth $4.14M as of Q3 2022.
FourThought Financial bought 1,379 AbbVie shares in Q3 2022, an estimated $198K.
AbbVie made up 0.61% of FourThought Financial's portfolio in Q3 2022, its #43 holding.
FourThought Financial first reported a position in AbbVie in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's AbbVie position peaked at $4.53M in Q1 2022.
2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.